111 Inc. ADR (YI)
NASDAQ: YIConsumer StaplesRetail-Drug Stores and Proprietary StoresUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
YI stock chart
Technical analysisKey statistics
All statistics- Market cap
- $20.76M
- P/E (TTM)
- 0.23
- Forward P/E
- 16.86
- EPS (TTM)
- $10.26
- Dividend yield
- None
- 52-week range
- 2.34 – 11.17
- Day range
- 2.34 – 2.67
- Volume / Avg
- 19.47K / 15.93K
- Beta
- —
- Shares outstanding
- 5.20M
- Next earnings
- Dec 16, 2026
52-week range
YI stock today
111 (YI) closed at $2.36 on Nov 20, down 5.98% (-$0.15), versus the S&P 500's 3.70% decline. At this level, YI sits near the bottom of its 52-week range of $2.34 to $11.17: 78.9% below the high, set on Jan 30, 2026 and 0.9% above the low. YI is down 7.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 35.5%.
111 trades at 0.2x its trailing twelve-month earnings per share of $10.26. Its forward P/E of 16.9x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. 111's next earnings report is expected on Dec 16, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About 111
Company profile111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services.
- Sector
- Consumer Staples
- Industry
- Retail-Drug Stores and Proprietary Stores
- CEO
- Mr. Junling Liu
- Headquarters
- Shanghai
- Employees
- 1,063
- IPO year
- 2018
- Website
- corporate.111.com.cn
Financial highlights
Full financialsIn fiscal 2025, 111 generated $1.80 billion in revenue, down 9.0% from fiscal 2024, its first annual decline since 2024. 111 reported a net loss of $3.2 million, compared with a loss of $2.8 million a year earlier. Gross margin was 5.8% (flat year over year) and operating margin -0.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.80B | $1.97B | $2.11B | $1.96B | $1.95B |
| Growth | -9.00% | -6.29% | +7.43% | +0.50% | +55.10% |
| Net income | $-3.22M | $-2.85M | $-49.78M | $-54.53M | $-97.45M |
| EPS (diluted) | $-0.05 | $-0.05 | $-0.33 | $-0.36 | $-0.63 |
Earnings
Earnings history- Next report
- Dec 16, 2026
YI news
All YI news111 peers
Consumer Staples sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PETSPetMed Express Inc. | 0.8501 | -8.04% | $18.90M | vs YI |
| RDGTRidgetech Inc. | 0.94 | -7.44% | $3.41M | vs YI |
| GRDNGuardian Pharmacy Services Inc. Class A | 46.94 | +0.58% | $2.97B | vs YI |
| CVSCVS Health Corporation | 80.84 | +1.00% | $103.43B | vs YI |
Indexes, lists and sector
Largest Consumer Staples stocks
111 stock FAQ
What is 111's stock price today?
YI last traded at $2.36 as of Nov 20, 4:00 PM EST, down 5.98% on the day. Prices are delayed at least 15 minutes.
When is 111's next earnings date?
111 is expected to report earnings on Wednesday, December 16, 2026.
What is YI's P/E ratio?
YI trades at a trailing P/E ratio of 0.23 and a forward P/E of 16.86.
Who is 111's CEO?
Mr. Junling Liu is the chief executive officer of 111 Inc. ADR, which has about 1,063 employees.
What is the YI 52-week high?
The 52-week high for YI is $11.17 and the 52-week low is $2.34. The stock is currently 78.9% below its high.